24/7 Wall St.
08-27-2008, 11:10 AM
24/7 Wall St. Daily News
http://www.247wallst.com/images/2008/08/27/95129c.jpg</img> (http://247wallstreet.typepad.com/.shared/image.html?/photos/uncategorized/2008/08/27/95129c.jpg)Cell Genesys CEO Stephen A. Sherwin, M.D made $1.3 million last year, with $577,500 coming from base salary. He did so well, in the eyes of the board, that his base was raised (http://www.sec.gov/Archives/edgar/data/865231/000119312508083658/ddef14a.htm) to $602,500. Who knows how well he will do with bonuses and perks.
CEGE blew up today. The company ended a clinical trial of its prostate cancer vaccine GVAX because patients who were treated with the vaccine were dying more frequently than those only given a standard treatment.
That bit of bad news took the shares down to $.69 from a 52-week high of $4.67.
The market cap of Cell Genesys is only $62 million now, so Dr. Sherwin is doing a bit too well.
Douglas A. McIntyre
http://feeds.feedburner.com/~f/typepad/RyNm?i=IdVzPK</img> (http://feeds.feedburner.com/~f/typepad/RyNm?a=IdVzPK) http://feeds.feedburner.com/~f/typepad/RyNm?i=BfpDdK</img> (http://feeds.feedburner.com/~f/typepad/RyNm?a=BfpDdK) http://feeds.feedburner.com/~f/typepad/RyNm?i=zSrRtk</img> (http://feeds.feedburner.com/~f/typepad/RyNm?a=zSrRtk)
complete story here... (http://www.247wallst.com/2008/08/247-wall-st--12.html)
http://www.247wallst.com/images/2008/08/27/95129c.jpg</img> (http://247wallstreet.typepad.com/.shared/image.html?/photos/uncategorized/2008/08/27/95129c.jpg)Cell Genesys CEO Stephen A. Sherwin, M.D made $1.3 million last year, with $577,500 coming from base salary. He did so well, in the eyes of the board, that his base was raised (http://www.sec.gov/Archives/edgar/data/865231/000119312508083658/ddef14a.htm) to $602,500. Who knows how well he will do with bonuses and perks.
CEGE blew up today. The company ended a clinical trial of its prostate cancer vaccine GVAX because patients who were treated with the vaccine were dying more frequently than those only given a standard treatment.
That bit of bad news took the shares down to $.69 from a 52-week high of $4.67.
The market cap of Cell Genesys is only $62 million now, so Dr. Sherwin is doing a bit too well.
Douglas A. McIntyre
http://feeds.feedburner.com/~f/typepad/RyNm?i=IdVzPK</img> (http://feeds.feedburner.com/~f/typepad/RyNm?a=IdVzPK) http://feeds.feedburner.com/~f/typepad/RyNm?i=BfpDdK</img> (http://feeds.feedburner.com/~f/typepad/RyNm?a=BfpDdK) http://feeds.feedburner.com/~f/typepad/RyNm?i=zSrRtk</img> (http://feeds.feedburner.com/~f/typepad/RyNm?a=zSrRtk)
complete story here... (http://www.247wallst.com/2008/08/247-wall-st--12.html)